aspirin has been researched along with pd 98059 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Badimon, L; Martínez-González, J; Viñals, M | 1 |
| Castranova, V; Chen, F; Ding, M; Leonard, SS; Lu, Y; Shi, X; Vallyathan, V | 1 |
| Abiru, S; Eguchi, K; Hamasaki, K; Ichikawa, T; Ishikawa, H; Migita, K; Nakao, K; Nakata, K; Sakamoto, M; Shigeno, M | 1 |
| Ago, T; Iida, M; Iwase, M; Kitazono, T; Nakamura, U; Ueta, M; Wakisaka, M; Yoshinari, M | 1 |
| Fishman, DA; Kang, S; Luo, R; Meng, Y; Smicun, Y | 1 |
| Jiang, R; Wang, L; Wei, L; Wu, J; Zhu, M | 1 |
| Cheng, Y; Gao, H; Gong, B; Hu, J; Huang, L; Li, W; Liu, H; Qiao, C; Wang, X; Zhao, C; Zong, L | 1 |
8 other study(ies) available for aspirin and pd 98059
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Regulatory effects of HDL on smooth muscle cell prostacyclin release.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aspirin; Cells, Cultured; Cholesterol, HDL; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Dactinomycin; Dexamethasone; Enzyme Inhibitors; Epoprostenol; Flavonoids; Gene Expression Regulation, Enzymologic; Indoles; Isoenzymes; Maleimides; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phospholipases A; Prostaglandin-Endoperoxide Synthases; Protein Kinase C; Protein Synthesis Inhibitors; Rabbits; RNA, Messenger | 1999 |
Participation of MAP kinase p38 and IkappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation.
Topics: Animals; Antioxidants; Aspirin; Cell Line; Chromates; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Flavonoids; I-kappa B Kinase; Imidazoles; Macrophages; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Reactive Oxygen Species; Transcription Factor AP-1; Transfection | 2000 |
Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Hepatocellular; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Isoenzymes; Liver Neoplasms; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; NF-kappa B; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Sulfonamides; Transcription Factor AP-1; Tumor Cells, Cultured | 2002 |
PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose.
Topics: Actins; Angiotensin II; Animals; Aspirin; Cells, Cultured; Cyclooxygenase Inhibitors; DNA, Antisense; Enzyme Inhibitors; Flavonoids; Gene Expression; Glomerular Mesangium; Glucose; Hypoglycemic Agents; Indomethacin; Ligands; Pioglitazone; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Vasoconstrictor Agents | 2004 |
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation.
Topics: Animals; Antigen Presentation; Antigens, Surface; Apoptosis; Aspirin; Cell Line, Tumor; Cell Membrane; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fas Ligand Protein; Female; Flavonoids; Humans; Lymphocyte Activation; Lymphocytes; Lysophospholipids; Membrane Glycoproteins; Nitrobenzenes; Ovarian Neoplasms; Quinazolines; Signal Transduction; Sulfonamides; Tumor Necrosis Factors; Tyrphostins | 2006 |
Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchi; Cell Line; Chemokine CX3CL1; Chromones; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Lipopolysaccharides; Matrix Metalloproteinase 12; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrrolidines; Respiratory Mucosa; Thiocarbamates | 2016 |
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; MAP Kinase Signaling System; Monocrotaline; Nitric Oxide Synthase Type III; Protein Kinase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Systole; Vascular Remodeling | 2017 |